Artelo Biosciences, Inc. (ARTL)
5.61
-0.37
(-6.19%)
USD |
NASDAQ |
Sep 10, 13:09
Artelo Biosciences Price to Book Value : 4.702 for Sept. 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 5.012 |
| September 08, 2026 | 5.188 |
| September 04, 2026 | 5.063 |
| September 03, 2026 | 5.214 |
| September 02, 2026 | 5.465 |
| September 01, 2026 | 5.159 |
| August 31, 2026 | 5.331 |
| August 28, 2026 | 4.999 |
| August 27, 2026 | 4.986 |
| August 26, 2026 | 5.360 |
| August 25, 2026 | 5.410 |
| August 24, 2026 | 5.198 |
| August 21, 2026 | 5.220 |
| August 20, 2026 | 5.374 |
| August 19, 2026 | 5.431 |
| August 18, 2026 | 5.506 |
| August 17, 2026 | 5.439 |
| August 14, 2026 | 5.961 |
| August 13, 2026 | 5.723 |
| August 12, 2026 | 5.530 |
| August 11, 2026 | 5.618 |
| August 10, 2026 | 5.319 |
| August 07, 2026 | 5.439 |
| August 06, 2026 | 5.676 |
| August 05, 2026 | 5.668 |
| Date | Value |
|---|---|
| August 04, 2026 | 5.772 |
| August 03, 2026 | 5.603 |
| July 31, 2026 | 5.809 |
| July 30, 2026 | 5.697 |
| July 29, 2026 | 5.457 |
| July 28, 2026 | 6.639 |
| July 27, 2026 | 7.619 |
| July 24, 2026 | 7.694 |
| July 23, 2026 | 7.996 |
| July 22, 2026 | 8.072 |
| July 21, 2026 | 8.449 |
| July 20, 2026 | 8.449 |
| July 17, 2026 | 8.675 |
| July 16, 2026 | 8.600 |
| July 15, 2026 | 8.675 |
| July 14, 2026 | 8.751 |
| July 13, 2026 | 7.921 |
| July 10, 2026 | 8.147 |
| July 09, 2026 | 7.694 |
| July 08, 2026 | 7.516 |
| July 07, 2026 | 7.581 |
| July 06, 2026 | 8.223 |
| July 02, 2026 | 8.374 |
| July 01, 2026 | 8.298 |
| June 30, 2026 | 8.449 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.710 |
| Corcept Therapeutics, Inc. | 17.65 |
| Veru, Inc. | 1.508 |
| Johnson & Johnson | 7.553 |
| Eli Lilly & Co. | 31.31 |
Price to Book Value Related Metrics
| Price | 5.61 |
| Earnings Yield | -409.7% |
| Market Cap | 23.50M |